Clinical Trial

Ablative Stereotactic MR-Guided Adaptive Reirradiation

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This research study will enroll people who have cancer in their abdomen or pelvis that was treated previously with radiation therapy. The purpose of this research study is to test the safety and possible harms of treating tumors in these regions with another round of radiation therapy, called reirradiation or "reRT." The researchers want to find out what effects (good and bad) reRT has in people with cancer in the abdomen and pelvis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-04-30; most recent amendment 2026-02-13.
Status change: Recruiting → Active, Not Recruiting 2026-02-13
Status change: Not Yet Recruiting → Recruiting 2024-06-14
Trial Details
NCT Number NCT06397573
Lead Sponsor Baptist Health South Florida
Conditions Abdominal Cancer, Pelvic Cancer
Enrollment 10 participants
Start Date 2024-06-05
Primary Completion 2026-08 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-17